Patent · US Active

Tumor-specific cleavable linkers

US12280120B2 · kind B2 · utility

0Cited by
72References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 24, 2021
Grant dateApr 22, 2025
Priority date
Expiry dateNov 24, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides tumor-specific cleavable linkers and their use in drugs and prodrugs for delivering therapeutics to a tumor cell environment. The present disclosure also provides cleavage products of said drugs and prodrugs, and methods related to the use of the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.